Study: Jillella 2026, Phytotherapy Research
A Prospective, Randomized, Double-Blind, Placebo-Controlled Clinical Study of Efficacy and Safety of Ashwagandha Root Extract Capsule on Skin and Hair Health in Healthy Adults
Citation
Jillella A, Keerthi N, Venkateswar Reddy J (2026). Phytotherapy Research. PubMed id 41770039.
Cards that cite this study (1)
Each card gives its own wording for who was tested, how and what was found.
- Ashwagandha: cortisol, mood, skin, hair, heart, kidneys and liver Tier B thin
B Adults aged 18 to 60 with hair loss or skin conditions (number not stated in the abstract), one clinic in Hyderabad, India (n=not stated in the abstract)
Randomised, double-blind, placebo-controlled, 300 mg standardised root extract twice a day for 75 days.
Greater improvement than placebo in transepidermal water loss (skin barrier), in hair density, growth and anagen:telogen ratio, and in skin and hair quality-of-life scores. No adverse events. The extract was supplied by the manufacturer, Ixoreal Biomed.
As recorded in this card: Jillella A, Keerthi N, Venkateswar Reddy J (2026), Phytotherapy Research, [primary]
Note: One clinic, manufacturer-supplied product, sample size not in the abstract. Ethnicity and hair type not stated, so nothing is known about afro-textured hair or skin of colour.
This is information, not medical advice. If you are worried, see a doctor or pharmacist. How we grade the evidence. All studies.